Thursday, 16 April 2020

No Hydroxychloroquine Benefit in Randomized COVID-19 Trial

The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquine can benefit COVID-19 patients or harm them.



from WebMD Health https://ift.tt/2KcEOnS

Related Posts:

0 comments:

Post a Comment